Apolipoprotein E Gene Variants of Alzheimer's Disease and Vascular Dementia Patients in a Community Population of Nanking

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|10|8|783-788

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.10, Iss.8, 2014-01, pp. : 783-788

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galantamine is beneficial in both patients with vascular dementia and patients with Alzheimer's disease with cerebrovascular disease

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Apolipoprotein E and Alzheimer’s Disease: Therapeutic Implications

By Higuchi M.  

CNS Drugs, Vol. 11, Iss. 6, 1999-06 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimer’s Disease with Cerebrovascular Disease

By Small G.  

CNS Drugs, Vol. 17, Iss. 12, 2003-01 ,pp. : 905-914

Adis International

Access to resources Recommend Favorite

Cerebral Arachidonate Cascade in Dementia: Alzheimer's Disease and Vascular Dementia

By  

Current Neuropharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 87-100

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia

By  

Current Pharmaceutical Design, Vol. 20, Iss. 38, 2014-11 ,pp. : 6007-6013

Bentham Science Publishers

Access to resources Recommend Favorite